A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2002 by Triangle Pharmaceuticals.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Triangle Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00044135
First received: August 20, 2002
Last updated: June 23, 2005
Last verified: November 2002
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given